INJECTION SITE VASCULITIS

This adverse event was reported 57 times

INJECTION SITE VASCULITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERYTHROMYCIN LACTOBIONATE 1 0.0068
1 EPIRUBICIN HYDROCHLORIDE 6 0.0009
2 FOSAPREPITANT DIMEGLUMINE 12 0.0009
3 RILONACEPT 1 0.0009
4 CYCLOSERINE 2 0.0009
5 ARGATROBAN 1 0.0007
6 ROMIDEPSIN 1 0.0006
7 IMIPENEM AND CILASTATIN SODIUM 1 0.0005
8 TOPOTECAN HYDROCHLORIDE 1 0.0004
9 BENDAMUSTINE HYDROCHLORIDE 3 0.0004
See all drugs enriched for association with INJECTION SITE VASCULITIS